W
WLC

Topic

GLP-1 longevity clinic

2 articles on glp-1 longevity clinic in longevity medicine. View all news →

Victoria Department of Health retatrutide health alert Peer-reviewed

Retatrutide Safety Alert: What Longevity Clinic Buyers Should Know About Unapproved Peptides

Retatrutide is promising in obesity trials, but products sold as retatrutide outside trials have triggered liver-toxicity warnings. Here is how clinic buyers can separate legitimate care from grey-market peptide risk.

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes Peer-reviewed

GLP-1s in Longevity Clinics: Metabolic Health, Muscle Loss, and Red Flags (2026)

A 2026 buyer guide to GLP-1s in longevity clinics: when they make medical sense, how to protect muscle, and which red flags to avoid.